Clinical Trial Update: To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ATEV with arteriovenous fistula (AVF) in female patients with end-stage renal disease requiring hemodialysis. The study is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• ATEV

Snippet

Sponsor: Humacyte, Inc. | Conditions: End Stage Renal Disease (ESRD) | Phase 3 | Status: RECRUITING